Compare Neurocrine Biosciences Inc (NBIX) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs NRG Energy Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while NRG Energy Inc trades at $132.3 (market cap $27.55B). The key difference: NRG Energy Inc is the larger of the two by market cap, and NRG Energy Inc pays a 1.46% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | NRG | |
|---|---|---|
Market Cap | $17.40B | $27.55B |
Sector | Health | Utilities |
52-Week High | $180.55 | $184.03 |
52-Week Low | $123.10 | $120.65 |
Enterprise Value | $16.49B | $51.38B |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
